Patents-Review.com
ClassID:

109207 ⎘

C12N2310/3533 - CPC Classification

Classification description:

Structure or type of the nucleic acid; Chemical structure; Nature of the modification linked to the nucleic acid via an atom other than carbon Halogen

Recent Application in this class:
#1
20250346901
2025-11-13

5-HALOURACIL-MODIFIED MICRORNAS AND THEIR USE IN THE TREATMENT OF CANCER

 #2
20250333737
2025-10-30

17ß-HYDROXYSTEROID DEHYDROGENASE TYPE 13 (HSD17B13) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

 #3
20250320494
2025-10-16

INHIBITORS OF EXPRESSION AND/OR FUNCTION

 #4
20250188456
2025-06-12

HIGH MOBILITY GROUP BOX-1 (HMGB1) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

 #5
20250145997
2025-05-08

Antisense Nucleic Acids

 #6
20250075211
2025-03-06

TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED DISEASES

 #7
20250066791
2025-02-27

RNA INTERFERENCE MEDIATED INHIBITION OF PROLYL HYDROXYLASE DOMAIN 2 (PHD2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)

 #8
20250034566
2025-01-30

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

 #9
20250002908
2025-01-02

COMPOSITIONS AND METHODS FOR INHIBITING COMPLEMENT COMPONENT 3 EXPRESSION

 #10
20240327839
2024-10-03

NOVEL THERAPEUTIC DELIVERY MOIETIES AND USES THEREOF

 #11
20240318171
2024-09-26

CRISPR-BASED COMPOSITIONS AND METHODS OF USE

 #12
20240309387
2024-09-19

TMPRSS6 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

 #13
20240287524
2024-08-29

GLUCOKINASE (GCK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

 #14
20240254486
2024-08-01

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

 #15
20240229011
2024-07-11

MODIFIED NUCLEIC ACIDS, HYBRID GUIDE RNAS, AND USES THEREOF

 #16
20240191240
2024-06-13

DEFINED MULTI-CONJUGATES OLIGONUCLEOTIDES

 #17
20240100080
2024-03-28

METHODS FOR TREATING OR PREVENTING TTR-ASSOCIATED DISEASES USING TRANSTHYRETIN (TTR) iRNA COMPOSITIONS

 #18
20230365972
2023-11-16

5-HALOURACIL-MODIFIED MICRORNAS AND THEIR USE IN THE TREATMENT OF CANCER

 #19
20230365965
2023-11-16

SERPINC1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

 #20
20230022185
2023-01-26

Transthyretin (TTR) iRNA compositions and methods of use thereof for treating or preventing TTR-associated diseases

 #21
20220403382
2022-12-22

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

 #22
20220380772
2022-12-01

RNA interference mediated inhibition of prolyl hydroxylase domain 2 (PHD2) gene expression using short interfering nucleic acid (siNA)

 #23
20220290148
2022-09-15

Defined multi-conjugates oligonucleotides

 #24
20220213473
2022-07-07

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE LECT2 GENE

 #25
20220202847
2022-06-30

HIGH DENSITY LIPOPROTEIN BINDING PROTEIN (HDLBP/VIGILIN) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

 #26
20220195439
2022-06-23

TREATMENT OF GLIAL CELL DERIVED NEUROTROPHIC FACTOR (GDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO GDNF

 #27
20220162604
2022-05-26

ANTISENSE NUCLEIC ACIDS

 #28
20220090069
2022-03-24

OLIGONUCLEOTIDES FOR HTT-1A MODULATION

 #29
20220072029
2022-03-10

Bi specific aptamer

 #30
20220049252
2022-02-17

CHEMICALLY-MODIFIED RNAi CONSTRUCTS AND USES THEREOF

 #31
20210380985
2021-12-09

17ß-Hydroxysteroid Dehydrogenase Type 13 (HSD17B13) iRNA Compositions And Methods Of Use Thereof

 #32
20210346509
2021-11-11

GLP-1 receptor ligand moiety conjugated oligonucleotides and uses thereof

 #33
20210332361
2021-10-28

Aptamer therapeutics useful in the treatment of complement-related disorders

 #34
20210332358
2021-10-28

MINIATURIZED HAIRPIN RNAi TRIGGERS (mxRNA) AND METHODS OF USES THEREOF

 #35
20210254076
2021-08-19

TMPRSS6 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

 #36
20210254063
2021-08-19

SERPINC1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

 #37
20210171956
2021-06-10

Glucokinase (GCK) iRNA compositions and methods of use thereof

 #38
20210163952
2021-06-03

TMPRSS6 iRNA compositions and methods of use thereof

 #39
20210087558
2021-03-25

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

 #40
20200392511
2020-12-17

TMPRSS6 iRNA compositions and methods of use thereof

 #41
20200377889
2020-12-03

Transthyretin (TTR) iRNA compositions and methods of use thereof for treating or preventing TTR-associated diseases

 #42
20200332299
2020-10-22

RNA interference mediated inhibition of prolyl hydroxylase domain 2 (PHD2) gene expression using short interfering nucleic acid (SINA)

 #43
20200308588
2020-10-01

HIGH MOBILITY GROUP BOX-1 (HMGB1) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

 #44
20200291407
2020-09-17

TREATMENT OF GLIAL CELL DERIVED NEUROTROPHIC FACTOR (GDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO GDNF

 #45
20200216844
2020-07-09

SERPINC1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

 #46
20200181614
2020-06-11

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

 #47
20200149040
2020-05-14

Antisense nucleic acids

 #48
20200138847
2020-05-07

Myostatin iRNA compositions and methods of use thereof

 #49
20200109402
2020-04-09

Methods of reducing expression of x-inactivation escapee genes and autosomal genes

 #50
20200056167
2020-02-20

Modified nucleic acids, hybrid guide RNAs, and uses thereof

 #51
20200032260
2020-01-30

Compositions and methods for modulation of IKBKAP splicing

 #52
20190382751
2019-12-19

MODIFIED CRISPR RNA AND USES THEREOF

 #53
20190350962
2019-11-21

METHODS FOR TREATING OR PREVENTING TTR-ASSOCIATED DISEASES USING TRANSTHYRETIN (TTR) iRNA COMPOSITIONS

 #54
20190345492
2019-11-14

Transthyretin (TTR) iRNA compositions and methods of use thereof for treating or preventing TTR-associated diseases

 #55
20190343867
2019-11-14

Bi-specific aptamer

 #56
20190284562
2019-09-19

TMPRSS6 iRNA compositions and methods of use thereof

 #57
20190241894
2019-08-08

MOLECULAR RE-ENGINEERING OF EXCITATION-INHIBITION BALANCE IN MEMORY CIRCUITS

 #58
20190218549
2019-07-18

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

 #59
20190211341
2019-07-11

TMPRSS6 iRNA compositions and methods of use thereof

 #60
20190185858
2019-06-20

Aptamer therapeutics useful in the treatment of complement-related disorders

 #61
20190144869
2019-05-16

Allele-specific gene suppression

 #62
20190134214
2019-05-09

GLP-1 Receptor Ligand Moiety Conjugated Oligonucleotides and Uses Thereof

 #63
20190119674
2019-04-25

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE LECT2 GENE

 #64
20190085331
2019-03-21

Defined multi-conjugate oligonucleotides

 #65
20190071672
2019-03-07

Pharmaceutical Composition

 #66
20190062754
2019-02-28

5-halouracil-modified microRNAs and their use in the treatment of cancer

 #67
20190040394
2019-02-07

TREATMENT OF GLIAL CELL DERIVED NEUROTROPHIC FACTOR (GDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO GDNF

 #68
20190038768
2019-02-07

Modified RNAi agents

 #69
20190038658
2019-02-07

High density lipoprotein binding protein (Hdlbp/Vigilin) iRNA compositions and methods of use thereof

 #70
20180371464
2018-12-27

RNA interference in dermal and fibrotic indications

 #71
20180371457
2018-12-27

Compositions and methods for modulation of IKBKAP splicing

 #72
20180362977
2018-12-20

RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)

 #73
20180346910
2018-12-06

Serpina1 iRNA compositions and methods of use thereof

 #74
20180346906
2018-12-06

Methods of reducing expression of X-inactivation escapee genes and autosomal genes

 #75
20180312841
2018-11-01

RIG-I ligands and methods for producing them

 #76
20180258430
2018-09-13

Compositions and Methods for Inhibiting Gene Expression of Alpha-1 AntiTrypsin

 #77
20180237785
2018-08-23

Notch 1 specific siRNA molecule

 #78
20180230473
2018-08-16

Modified TGF-beta oligonucleotides

 #79
20180230470
2018-08-16

Compositions and methods for inhibiting gene expression of Hif2alpha

 #80
20180230468
2018-08-16

Treatment of atonal homolog 1 (ATOH1) related diseases by inhibition of natural antisense transcript to ATOH1

 #81
20180201930
2018-07-19

COMPOUNDS AND METHODS FOR MODULATING TARGET NUCLEAR AND SUB-NUCLEAR NUCLEIC ACID MOLECULES IN CELLS AND ANIMALS

 #82
20180201928
2018-07-19

Micromirs

 #83
20180200183
2018-07-19

2′ fluoro-modified RNAs as immunostimulators

 #84
20180195073
2018-07-12

Glucokinase (GCK) iRNA compositions and methods of use thereof

 #85
20180195071
2018-07-12

RNA interference mediated inhibition of hepatitis B Virus (HBV) gene expression using short interfering nucleic acid (siNA)

 #86
20180195062
2018-07-12

Pharmaceutical Composition

 #87
20180179523
2018-06-28

CRISPR-BASED COMPOSITIONS AND METHODS OF USE

 #88
20180155718
2018-06-07

RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionality

 #89
20180148725
2018-05-31

UNA oligomers and compositions for treating amyloidosis

 #90
20180135057
2018-05-17

Compositions and methods for inhibiting expression of the LECT2 gene

 #91
20180119152
2018-05-03

Antisense compounds targeting genes associated with cystic fibrosis

 #92
20180105812
2018-04-19

Short interfering nucleic acid (siNA) compositions

 #93
20180100154
2018-04-12

RNA interference mediated inhibition of prolyl hydroxylase domain 2 (PHD2) gene expression using short interfering nucleic acid (siNA)

 #94
20180094263
2018-04-05

Oligonucleotide compounds for targeting huntingtin mRNA

 #95
20180087058
2018-03-29

TMPRSS6 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

 #96
20180087055
2018-03-29

MODIFIED TGF-BETA2 OLIGONUCLEOTIDES

 #97
20180080024
2018-03-22

Single-stranded RNAi agents containing an internal, non-nucleic acid spacer

 #98
20180066254
2018-03-08

RNA interference mediated therapy for neurodegenerative diseases

 #99
20180051283
2018-02-22

Compositions and methods for modulating Tau expression

 #100
20180044679
2018-02-15

Composition for treating cancer associated with HPV infection

 #101
20180037886
2018-02-08

Compositions and methods for inhibiting expression of the ALAS1 gene

 #102
20180030446
2018-02-01

APTAMER THERAPEUTICS USEFUL IN THE TREATMENT OF COMPLEMENT-RELATED DISORDERS

 #103
20180023084
2018-01-25

Disulfide-containing alkyne linking agents

 #104
20170362594
2017-12-21

TMPRSS6 iRNA compositions and methods of use thereof

 #105
20170327823
2017-11-16

Selective Reactivation of Genes on the Inactive X Chromosome

 #106
20170260531
2017-09-14

Post-selec modification methods

 #107
20170240900
2017-08-24

RAS exon 2 skipping for cancer treatment

 #108
20170226516
2017-08-10

TREATMENT OF GLIAL CELL DERIVED NEUROTROPHIC FACTOR (GDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO GDNF

 #109
20170191066
2017-07-06

Antisense compounds targeting apolipoprotein E receptor 2

 #110
20170152515
2017-06-01

Treatment of atonal homolog 1 (ATOH1) related diseases by inhibition of natural antisense transcript to ATOH1

 #111
20170029817
2017-02-02

Transthyretin (TTR) iRNA compositions and methods of use thereof for treating or preventing TTR-associated diseases

 #112
20160376588
2016-12-29

Molecular re-engineering of excitation-inhibition balance in memory circuits

 #113
20160298123
2016-10-13

RNA INTERFERENCE MEDIATED INHIBITION OF PROLYL HYDROXYLASE DOMAIN 2 (PHD2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)

 #114
20160264966
2016-09-15

Compositions and methods for inhibiting expression of the LECT2 gene

 #115
20160257962
2016-09-08

RNA INTERFERENCE MEDIATED INHIBITION OF ISOCITRATE DEHYDROGENASE (IDH1) GENE EXPRESSION

 #116
20160257954
2016-09-08

SERPINC1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

 #117
20160244767
2016-08-25

Antisense compounds targeting genes associated with cystic fibrosis

 #118
20160194638
2016-07-07

Compounds and methods for modulating target nuclear and sub-nuclear nucleic acid molecules in cells and animals

 #119
20160194637
2016-07-07

Compounds and methods for modulating target nuclear and sub-nuclear nucleic acid molecules in cells and animals

 #120
20160186172
2016-06-30

Compositions and methods for inhibiting hepcidin antimicrobial peptide (HAMP) or HAMP-related gene expression

 #121
20160152983
2016-06-02

RIG-I ligands and methods for producing them

 #122
20160145629
2016-05-26

TMPRSS6 iRNA compositions and methods of use thereof

 #123
20160145622
2016-05-26

Dengue virus-specific siRNA, double helix oligo-RNA structure comprising siRNA, and composition for suppressing proliferation of dengue virus comprising RNA structure

 #124
20160053265
2016-02-25

Cell-specific internalizing RNA aptamers against human CCR5 and uses therefore

 #125
20160046944
2016-02-18

Aptamer to IL-17 and use thereof

 #126
20160040164
2016-02-11

Selection of RNA-aptamers as anti-malaria agents

 #127
20160032293
2016-02-04

Selection of RNA-aptamers as anti-malaria agents

 #128
20150315579
2015-11-05

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

 #129
20150299711
2015-10-22

Composition for treating cancer associated with HPV infection

 #130
20150291956
2015-10-15

RNA TARGETED TO BETA CATENIN

 #131
20150275217
2015-10-01

RIG-I ligands and methods for producing them

 #132
20150275215
2015-10-01

Neutralizing RNA aptamers

 #133
20150225717
2015-08-13

Selective reactivation of genes on the inactive X chromosome

 #134
20150159158
2015-06-11

Aptamer therapeutics useful in the treatment of complement-related disorders

 #135
20150017163
2015-01-15

Methods for Treating or Preventing Ophthalmological Conditions

 #136
20140316121
2014-10-23

Methods and compounds useful in conditions related to repeat expansion

 #137
20140127325
2014-05-08

Compositions and method for inhibiting hepcidin antimicrobial peptide (HAMP) or HAMP-related gene expression

 #138
20140031537
2014-01-30

Oligonucleotides for modulation of target RNA activity

 #139
20130289100
2013-10-31

Subunit-selective nucleic acid inhibitors of glutamate receptors

 #140
20130289092
2013-10-31

Compounds and methods for modulating interaction between proteins and target nucleic acids

 #141
20130165500
2013-06-27

RNA interference mediated inhibition of prolyl hydroxylase domain 2 (PHD2) gene expression using short interfering nucleic acid (siNA)

 #142
20130035369
2013-02-07

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

 #143
20120322860
2012-12-20

Aptamer therapeutics useful in the treatment of complement-related disorders

 #144
20120283312
2012-11-08

Modulation of eIF4E expression

 #145
20120264815
2012-10-18

Reversible platelet inhibition

 #146
20120259001
2012-10-11

Duplex oligonucleotides with enhanced functionality in gene regulation

 #147
20120238618
2012-09-20

Antisense oligonucleotides for inhibition of microRNA-21

 #148
20120183602
2012-07-19

Lipid formulation

 #149
20120165401
2012-06-28

Aptamer for chymase, and use thereof

 #150
20120115936
2012-05-10

Potent anti APOB antisense compounds

 #151
20120100136
2012-04-26

METHODS FOR TREATING OR PREVENTING OPHTHALMOLOGICAL DISEASES

 #152
20120095085
2012-04-19

NUCLEIC ACID MODULATORS OF CLEC-2

 #153
20120083596
2012-04-05

Pharmaceutical Composition

 #154
20120065243
2012-03-15

RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionality

 #155
20120058144
2012-03-08

Lipids and compositions for the delivery of therapeutics

 #156
20120053227
2012-03-01

miR-33 INHIBITORS AND USES THEREOF

 #157
20120029054
2012-02-02

RNA Interference Mediated Inhibition of GATA Binding Protein 3 (GATA3) Gene Expression Using Short Intefering Nucleic Acid (siNA)

 #158
20120029053
2012-02-02

Short interfering ribonucleic acid (siRNA) for oral administration

 #159
20120029052
2012-02-02

Short interfering ribonucleic acid (siRNA) for oral administration

 #160
20120022143
2012-01-26

RNA Interference Mediated Inhibition of the Thymic Stromal Lymphopoietin (TSLP) Gene Expression Using Short Interfering Nucliec Acid (siNA)

 #161
20120022142
2012-01-26

RNA Interference Mediated Inhibition of Signal Transducer and Activator of Transcription 1 (STAT1) Gene Expression Using Short Interfering Nucleic Acid (siNA)

 #162
20120022139
2012-01-26

Short interfering ribonucleic acid (siRNA) for oral administration

 #163
20120016011
2012-01-19

RNA Interference Mediated Inhibition of Connective Tissue Growth Factor (CTGF) Gene Expression Using Short Interfering Nucleic Acid (siNA)

 #164
20120016009
2012-01-19

Optimized Methods For Delivery Of DSRNA Targeting The PCSK9 Gene

 #165
20120014875
2012-01-19

Nucleic acid aptamers

 #166
20120010272
2012-01-12

RNA Interference Mediated Inhibition of Apoptosis Signal-Regulating Kinase 1 (ASK1) Gene Expression Using Short Interfering Nucleic Acid (siNA)

 #167
20120004282
2012-01-05

RNA Interference Mediated Inhibition of the Intercellular Adhesion Molecule 1 (ICAM-1) Gene Expression Using Short Interfering Nucleic Acid (siNA)

 #168
20120004281
2012-01-05

RNA Interference Mediated Inhibition of the Nerve Growth Factor Beta Chain (NGFB) Gene Expression Using Short Interfering Nucleic Acid (siNA)

 #169
20120004280
2012-01-05

RNA interference mediated inhibition of the FCεR1α gene

 #170
20110319476
2011-12-29

TREATMENT OF GLIAL CELL DERIVED NEUROTROPHIC FACTOR (GDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO GDNF

 #171
20110294869
2011-12-01

Self delivering bio-labile phosphate protected pro-oligos for oligonucleotide based therapeutics and mediating RNA interference

 #172
20110060027
2011-03-10

Aptamer therapeutics useful in the treatment of complement-related disorders

 #173
20110046206
2011-02-24

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

 #174
20110039334
2011-02-17

Chimeric oligomeric compounds for modulation of splicing

 #175
20110038871
2011-02-17

CCR2 INHIBITORS FOR TREATING CONDITIONS OF THE EYE

 #176
20110015251
2011-01-20

RNA interference mediated inhibition of human immunodeficiency virus (HIV) gene expression using short interfering nucleic acid (siNA)

 #177
20110003886
2011-01-06

Selection of RNA-aptamers as anti-malaria agents

 #178
20100330035
2010-12-30

Pharmaceutical compositions for treatment of HCV patients that are poor-responders to interferon

 #179
20100324120
2010-12-23

Lipid formulation

 #180
20100311812
2010-12-09

RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA)

 #181
20100298410
2010-11-25

MicromiRs

 #182
20100286234
2010-11-11

Pharmaceutical composition comprising anti-mirna antisense oligonucleotide

 #183
20100280099
2010-11-04

Combination treatment for the treatment of hepatitis C virus infection

 #184
20100234450
2010-09-16

Molecular targeting agents

 #185
20100222413
2010-09-02

Chemically modified oligonucleotides for use in modulation micro RNA and uses thereof

 #186
20100216982
2010-08-26

Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation

 #187
20100184825
2010-07-22

RNA interference mediated inhibition of protein tyrosine phosphatase-1B (PTP-1B) gene expression using short interfering nucleic acid (siNA)

 #188
20100168205
2010-07-01

Methods and Compositions for Prevention or Treatment of RSV Infection Using Modified Duplex RNA Molecules

 #189
20100130589
2010-05-27

MODULATION OF eIF4E EXPRESSION

 #190
20100124547
2010-05-20

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF FACTOR VII GENES

 #191
20100093836
2010-04-15

COMPOUNDS AND METHODS FOR MODULATING PROTEIN EXPRESSION

 #192
20100015707
2010-01-21

Short interfering ribonucleic acid (siRNA) with improved pharmacological properties

 #193
20100010066
2010-01-14

Optimized Methods For Delivery Of DSRNA Targeting The PCSK9 Gene

 #194
20100009451
2010-01-14

COMPOSITIONS AND METHODS FOR SPECIFICALLY SILENCING A TARGET NUCLEIC ACID

 #195
20100004320
2010-01-07

Pharmaceutical Composition

 #196
20090306178
2009-12-10

CONJUGATED DOUBLE STRAND COMPOSITIONS FOR USE IN GENE MODULATION

 #197
20090291131
2009-11-26

Silencing of polo-like kinase expression using interfering RNA

 #198
20090286851
2009-11-19

Compositions and methods for delivering RNAI using lipoproteins

 #199
20090281164
2009-11-12

RNA interference mediated inhibition of respiratory syncytial virus (RSV) expression using short interfering nucleic acid (siNA)

 #200
20090221807
2009-09-03

2' Deoxy-2'-Alkylnucleotide Containing Nucleic Acid

 #201
20090209626
2009-08-20

Duplex oligonucleotides with enhanced functionality in gene regulation

 #202
20090198047
2009-08-06

2'-Modified Oligonucleotides

 #203
20090192106
2009-07-30

Modulation of eIF4E expression

 #204
20090192105
2009-07-30

RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCELIC ACID (siNA)

 #205
20090143326
2009-06-04

MicroRNAs

 #206
20090137513
2009-05-28

RNA Interference Mediated Inhibition of Acetyl-CoA-Carboxylase Gene Expression Using Short Interfering Nucleic Acid (siNA)

 #207
20090023675
2009-01-22

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

 #208
20080108801
2008-05-08

Lipophilic conjugated iRNA agents

 #209
20080039618
2008-02-14

POLYCYCLIC SUGAR SURROGATE-CONTAINING OLIGOMERIC COMPOUNDS AND COMPOSITIONS FOR USE IN GENE MODULATION

 #210
20080032945
2008-02-07

2'-MODIFIED OLIGONUCLEOTIDES

 #211
20070213292
2007-09-13

Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof

 #212
20070123482
2007-05-31

Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof

 #213
20070066549
2007-03-22

Modulation of eIF4E expression

 #214
20070032441
2007-02-08

Rna interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (sina)

 #215
20070010473
2007-01-11

Nucleic acid ligands to integrins

 #216
20060223990
2006-10-05

Synthesis, deprotection, analysis & purification of RNA & ribozymes

 #217
20060142557
2006-06-29

2'-deoxy-2'alkylnucleotide containing nucleic acid

 #218
20060018871
2006-01-26

Aptamer therapeutics useful in the treatment of complement-related disorders

 #219
20050245474
2005-11-03

Double stranded constructs comprising one or more short strands hybridized to a longer strand

 #220
20050176038
2005-08-11

Polymearase III-based expression of therapeutic RNAs

 #221
20050171039
2005-08-04

RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)

 #222
20050148530
2005-07-07

RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)

 #223
20050112563
2005-05-26

Gapped 2' modified oligonucleotides

 #224
20050079610
2005-04-14

RNA interference mediated inhibition of Fos gene expression using short interfering nucleic acid (siNA)

 #225
20050026160
2005-02-03

Compositions comprising alternating 2′-modified nucleosides for use in gene modulation

 #226
17346548
2026-01-06

Binding and catalytic molecules built from expanded DNA